Gencor Industries, Inc.
AMEX:GENCAgricultural - Machinery
+$0.15 today
- Market cap
- $256.66M
- Beta
- 0.49
- P/E (TTM)
- 14.3
- EPS (TTM)
- $1.04
Volume 0.03M
Average 0.03M
GENC Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Gencor Industries, Inc.AMEX: GENC
Research & Development · Q2 FY2026 · quarter ended Mar 2026
Research & development declines year over year
Q2 FY2026 research & development of $629K fell 7.6% year over year, behind the -6.4% change in trailing-twelve-month research & development. Sequentially, it fell 17.0% from the prior quarter. Over 3 fiscal years it compounded at -13.9% a year.
Context
- Research & development amounted to 2.4% of revenue in FY2025, down 0.5 pp from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -7.6% toward the trailing-twelve-month pace of -6.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 2.76M USD
- Year-over-year change
- -16.8%
- 4-year CAGR
- -10.4%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 2.76M | -16.8% |
| FY2024 | 2024-09-30 | 3.31M | -4.2% |
| FY2023 | 2023-09-30 | 3.46M | -20.0% |
| FY2022 | 2022-09-30 | 4.33M | +1.1% |
| FY2021 | 2021-09-30 | 4.28M | — |
Research & Development vs competitors
How GENC compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -6.4% is the 2nd highest of 5, against a peer median of -82.0%.
- Research & development amounts to 2.7% of revenue for GENC, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $42.1M USD | -3.0% | +9.8% | 3.5% | |
| LTM Mar 2026 | $2.79M USD | -6.4% | -13.9% | 2.7% | |
SHMDSCHMID Group N.V. Class A Ordinary Shares | FY2025 | €1.43M EUR | -64.1% | -33.3% | 2.2% |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Feb 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding GENC) | — | -82.0% | -11.7% | 0.0% | |
Competitors are the stored peer set for GENC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 85.28M | 103.48M | 105.08M | 113.17M | 115.44M |
| Cost of Revenue | 67.1M | 82.94M | 76.04M | 81.84M | 83.72M |
| Gross Profit | 18.18M | 20.54M | 29.04M | 31.33M | 31.71M |
| Gross Margin | 21.3% | 19.9% | 27.6% | 27.7% | 27.5% |
| Research & Development | 4.28M | 4.33M | 3.46M | 3.31M | 2.76M |
| Selling, General & Admin | 13.2M | 12.05M | 12.15M | 14.33M | 14.94M |
| Operating Expenses | 17.48M | 16.38M | 15.61M | 17.64M | 17.7M |
| Depreciation & Amortization | 2.59M | 2.82M | 2.83M | 2.6M | 2.36M |
| EBITDA | 9.23M | 1.13M | 21.61M | 23.33M | 22.56M |
| EBITDA Margin | 10.8% | 1.1% | 20.6% | 20.6% | 19.5% |
| Operating Income | 701K | 4.17M | 13.43M | 13.69M | 14.02M |
| Operating Margin | 0.8% | 4.0% | 12.8% | 12.1% | 12.1% |
| Interest Income | 1.76M | 1.31M | 2.11M | 3.44M | 4.37M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 5.93M | (5.86M) | 5.35M | 7.04M | 6.18M |
| Income Before Tax | 6.63M | (1.69M) | 18.78M | 20.73M | 20.2M |
| Pre-Tax Margin | 7.8% | -1.6% | 17.9% | 18.3% | 17.5% |
| Income Tax Expense | 829K | (1.32M) | 4.11M | 6.17M | 4.54M |
| Net Income | 5.81M | (372K) | 14.67M | 14.56M | 15.66M |
| Net Margin | 6.8% | -0.4% | 14.0% | 12.9% | 13.6% |
| EPS (Basic) | 0.40 | (0.03) | 1.00 | 0.99 | 1.07 |
| EPS (Diluted) | 0.39 | (0.03) | 1.00 | 0.99 | 1.07 |
| Weighted Avg Shares | 14.61M | 14.66M | 14.66M | 14.66M | 14.66M |
| Weighted Avg Shares (Diluted) | 14.73M | 14.66M | 14.66M | 14.66M | 14.66M |
Gencor Industries, Inc.
AMEX:GENC
Intrinsic Alpha fair value
Locked
Current Price
$17.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.